Data / Form D filings / Brighton Biotech, Inc.
Brighton Biotech, Inc.: Form D filings
Brighton Biotech, Inc., a biotechnology company in Fort Worth, TX, filed 3 Form D notices with the SEC between 2014 and 2015. The latest, on June 1, 2015, reports an offering of no set size with nothing sold yet to 3 investors.
Find out what Brighton Biotech, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- FORT WORTH CLUB BLDG., 306 W. 7TH STREET, SUITE 860, Fort Worth, TX, 76102
- Phone
- (817) 821-3000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1625381
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 1, 2015 | New notice | Indefinite | $0 | Indefinite | 3 | May 26, 2015 | sec.gov |
| Nov 18, 2014 | Amendment | $2,500,000 | $1,600,000 | $900,000 | 20 | Nov 5, 2014 | sec.gov |
| Nov 18, 2014 | New notice | $2,500,000 | $1,600,000 | $900,000 | 20 | Nov 5, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kevin Howard Hershberger | Executive Officer, Director | |
| John A. White | Director | |
| Jeffrey A. Gelfand | Director | |
| Frances A. West | Director | |
| Halden Howard Connor | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Jun 1, 2015 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Brighton Biotech, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.